ELITE Stock Overview
Elite Diagnostic Limited provides diagnostic imaging services in Jamaica.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 2/6 |
| Dividends | 2/6 |
Elite Diagnostic Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JA$1.59 |
| 52 Week High | JA$2.62 |
| 52 Week Low | JA$1.41 |
| Beta | -0.14 |
| 1 Month Change | -7.56% |
| 3 Month Change | -5.92% |
| 1 Year Change | -36.65% |
| 3 Year Change | -45.17% |
| 5 Year Change | -45.17% |
| Change since IPO | -48.71% |
Recent News & Updates
Recent updates
Shareholder Returns
| ELITE | JM Healthcare | JM Market | |
|---|---|---|---|
| 7D | -4.2% | 0.2% | 0.9% |
| 1Y | -36.7% | -17.6% | -1.0% |
Return vs Industry: ELITE underperformed the JM Healthcare industry which returned -17.6% over the past year.
Return vs Market: ELITE underperformed the JM Market which returned -1% over the past year.
Price Volatility
| ELITE volatility | |
|---|---|
| ELITE Average Weekly Movement | 10.4% |
| Healthcare Industry Average Movement | 5.6% |
| Market Average Movement | 8.9% |
| 10% most volatile stocks in JM Market | 16.8% |
| 10% least volatile stocks in JM Market | 4.4% |
Stable Share Price: ELITE has not had significant price volatility in the past 3 months.
Volatility Over Time: ELITE's weekly volatility (10%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2012 | n/a | Harvey Levers | elite-diagnostic.com |
Elite Diagnostic Limited provides diagnostic imaging services in Jamaica. It offers magnetic resonance imaging, computed tomography scan, X-ray, ultrasound, and fluoroscopy. The company also provides radiology procedures, including angiograms, catheter insertion, aspirations and biopsy, selective hysterosalpingogram and recanalization, lumbar puncture, sclerotherapy, and implant placement services.
Elite Diagnostic Limited Fundamentals Summary
| ELITE fundamental statistics | |
|---|---|
| Market cap | JA$561.91m |
| Earnings (TTM) | JA$367.26k |
| Revenue (TTM) | JA$763.79m |
1,530x
P/E Ratio0.7x
P/S RatioIs ELITE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ELITE income statement (TTM) | |
|---|---|
| Revenue | JA$763.79m |
| Cost of Revenue | JA$272.76m |
| Gross Profit | JA$491.03m |
| Other Expenses | JA$490.67m |
| Earnings | JA$367.26k |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.001 |
| Gross Margin | 64.29% |
| Net Profit Margin | 0.048% |
| Debt/Equity Ratio | 85.5% |
How did ELITE perform over the long term?
See historical performance and comparison